A detailed history of Columbia Asset Management transactions in Gsk PLC stock. As of the latest transaction made, Columbia Asset Management holds 9,125 shares of GSK stock, worth $337,351. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,125
Previous 8,330 9.54%
Holding current value
$337,351
Previous $309,000 13.59%
% of portfolio
0.07%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$38.5 - $45.78 $30,607 - $36,395
795 Added 9.54%
9,125 $351,000
Q4 2023

Feb 09, 2024

SELL
$34.17 - $37.56 $55,697 - $61,222
-1,630 Reduced 16.37%
8,330 $309,000
Q3 2023

Nov 13, 2023

BUY
$33.81 - $38.07 $10,143 - $11,421
300 Added 3.11%
9,960 $361,000
Q2 2023

Aug 14, 2023

BUY
$33.6 - $38.32 $12,096 - $13,795
360 Added 3.87%
9,660 $344,000
Q1 2023

May 15, 2023

BUY
$33.5 - $36.43 $54,437 - $59,198
1,625 Added 21.17%
9,300 $331,000
Q4 2022

Feb 10, 2023

BUY
$30.0 - $37.92 $70,050 - $88,543
2,335 Added 43.73%
7,675 $270,000
Q3 2022

Nov 03, 2022

SELL
$16.13 - $44.61 $37,599 - $103,985
-2,331 Reduced 30.39%
5,340 $157,000
Q2 2022

Aug 26, 2022

SELL
$42.05 - $47.77 $87,926 - $99,887
-2,091 Reduced 21.42%
7,671 $334,000
Q4 2021

Feb 14, 2022

SELL
$38.88 - $45.31 $33,009 - $38,468
-849 Reduced 8.0%
9,762 $430,000
Q3 2021

Nov 15, 2021

SELL
$38.79 - $43.16 $11,055 - $12,300
-285 Reduced 2.62%
10,611 $405,000
Q2 2021

Aug 02, 2021

SELL
$36.52 - $41.46 $69,461 - $78,856
-1,902 Reduced 14.86%
10,896 $434,000
Q1 2021

May 28, 2021

SELL
$34.27 - $40.01 $117,134 - $136,754
-3,418 Reduced 21.08%
12,798 $457,000
Q4 2020

Feb 11, 2021

BUY
$34.07 - $39.94 $19,522 - $22,885
573 Added 3.66%
16,216 $597,000
Q3 2020

Nov 16, 2020

SELL
$38.11 - $42.99 $27,553 - $31,081
-723 Reduced 4.42%
15,643 $589,000
Q2 2020

Aug 14, 2020

BUY
$37.87 - $43.58 $78,580 - $90,428
2,075 Added 14.52%
16,366 $668,000
Q1 2020

May 14, 2020

SELL
$32.47 - $48.83 $31,658 - $47,609
-975 Reduced 6.39%
14,291 $542,000
Q3 2019

Nov 12, 2019

BUY
$40.46 - $43.52 $242 - $261
6 Added 0.04%
15,266 $652,000
Q2 2019

Aug 15, 2019

SELL
$39.4 - $42.7 $92,590 - $100,345
-2,350 Reduced 13.34%
15,260 $611,000
Q1 2019

May 20, 2019

BUY
$38.57 - $42.69 $91,796 - $101,602
2,380 Added 15.63%
17,610 $736,000
Q4 2018

Feb 12, 2019

BUY
$37.8 - $42.69 $3,779 - $4,269
100 Added 0.66%
15,230 $582,000
Q3 2018

Nov 06, 2018

SELL
$39.75 - $42.69 $49,687 - $53,362
-1,250 Reduced 7.63%
15,130 $608,000
Q1 2018

May 07, 2018

BUY
$36.18 - $40.15 $27,135 - $30,112
750 Added 4.8%
16,380 $640,000
Q4 2017

Feb 05, 2018

SELL
$35.34 - $41.9 $223,878 - $265,436
-6,335 Reduced 28.84%
15,630 $554,000
Q3 2017

Nov 07, 2017

BUY
$39.44 - $41.55 $866,299 - $912,645
21,965
21,965 $892,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $75.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Columbia Asset Management Portfolio

Follow Columbia Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.